OR WAIT null SECS
Boehringer Ingelheim Pharma GmbH & Co. KG.
Harald Bradl is director, cell culture development at Boehringer Ingelheim Pharma GmbH & Co. KG.
A modular cell-culture platform demonstrates accelerated process development.